Literature DB >> 10219910

The comparative pathology of human and mouse mammary glands.

R D Cardiff1, S R Wellings.   

Abstract

The mouse has emerged as a primary animal model for human breast cancer because the mammary glands of the two species are very similar in structure and function. In this regard the TDLU and LA have similar morphology. The mouse, infected by MMTV, develops "spontaneous" tumors with specific but limited tumor phenotypes. The advent of genetic manipulation has created transgenic mice that develop hyperplasias and tumors morphologically and cytochemically comparable to lesions in humans. Even experienced pathologists have difficulty distinguishing between lesions from the two species, and the morphological similarities support the utility of the mouse model in understanding human breast cancer. In this essay we review our experience with the histopathology of human and mouse mammary disease by comparing the normal gland with hyperplastic, dysplastic and neoplastic lesions of traditional and transgenic origin.

Entities:  

Mesh:

Year:  1999        PMID: 10219910     DOI: 10.1023/a:1018712905244

Source DB:  PubMed          Journal:  J Mammary Gland Biol Neoplasia        ISSN: 1083-3021            Impact factor:   2.673


  71 in total

Review 1.  Regulation of mammary gland growth and morphogenesis by the mammary fat pad: a species comparison.

Authors:  R C Hovey; T B McFadden; R M Akers
Journal:  J Mammary Gland Biol Neoplasia       Date:  1999-01       Impact factor: 2.673

2.  Persistent and atypical lobules in the human breast may be precancerous.

Authors:  S R Wellings; H M Jensen; M R DeVault
Journal:  Experientia       Date:  1976-11-15

Review 3.  Comparative study of human and rat mammary tumorigenesis.

Authors:  J Russo; B A Gusterson; A E Rogers; I H Russo; S R Wellings; M J van Zwieten
Journal:  Lab Invest       Date:  1990-03       Impact factor: 5.662

4.  Preneoplastic lesions in the human breast.

Authors:  H M Jensen; J R Rice; S R Wellings
Journal:  Science       Date:  1976-01-23       Impact factor: 47.728

Review 5.  Role of hormones in mammary cancer initiation and progression.

Authors:  I H Russo; J Russo
Journal:  J Mammary Gland Biol Neoplasia       Date:  1998-01       Impact factor: 2.673

6.  Requirement for both Shc and phosphatidylinositol 3' kinase signaling pathways in polyomavirus middle T-mediated mammary tumorigenesis.

Authors:  M A Webster; J N Hutchinson; M J Rauh; S K Muthuswamy; M Anton; C G Tortorice; R D Cardiff; F L Graham; J A Hassell; W J Muller
Journal:  Mol Cell Biol       Date:  1998-04       Impact factor: 4.272

7.  Expression of an activated Notch-related int-3 transgene interferes with cell differentiation and induces neoplastic transformation in mammary and salivary glands.

Authors:  C Jhappan; D Gallahan; C Stahle; E Chu; G H Smith; G Merlino; R Callahan
Journal:  Genes Dev       Date:  1992-03       Impact factor: 11.361

8.  Transforming growth factor-alpha promotes mammary tumorigenesis through selective survival and growth of secretory epithelial cells.

Authors:  G H Smith; R Sharp; E C Kordon; C Jhappan; G Merlino
Journal:  Am J Pathol       Date:  1995-10       Impact factor: 4.307

9.  Risk factors for breast cancer in women with proliferative breast disease.

Authors:  W D Dupont; D L Page
Journal:  N Engl J Med       Date:  1985-01-17       Impact factor: 91.245

10.  The int-2 gene product acts as an epithelial growth factor in transgenic mice.

Authors:  W J Muller; F S Lee; C Dickson; G Peters; P Pattengale; P Leder
Journal:  EMBO J       Date:  1990-03       Impact factor: 11.598

View more
  80 in total

Review 1.  Regulation of mammary gland growth and morphogenesis by the mammary fat pad: a species comparison.

Authors:  R C Hovey; T B McFadden; R M Akers
Journal:  J Mammary Gland Biol Neoplasia       Date:  1999-01       Impact factor: 2.673

Review 2.  How to Choose a Mouse Model of Breast Cancer, a Genomic Perspective.

Authors:  Matthew R Swiatnicki; Eran R Andrechek
Journal:  J Mammary Gland Biol Neoplasia       Date:  2019-06-21       Impact factor: 2.673

3.  Sustained trophism of the mammary gland is sufficient to accelerate and synchronize development of ErbB2/Neu-induced tumors.

Authors:  M D Landis; D D Seachrist; F W Abdul-Karim; R A Keri
Journal:  Oncogene       Date:  2006-01-23       Impact factor: 9.867

4.  Rb deletion in mouse mammary progenitors induces luminal-B or basal-like/EMT tumor subtypes depending on p53 status.

Authors:  Zhe Jiang; Tao Deng; Robert Jones; Huiqin Li; Jason I Herschkowitz; Jeff C Liu; Victor J Weigman; Ming-Sound Tsao; Timothy F Lane; Charles M Perou; Eldad Zacksenhaus
Journal:  J Clin Invest       Date:  2010-08-02       Impact factor: 14.808

5.  The effect of physical training on the N-methyl-N-nitrosourea-induced mammary carcinogenesis of Sprague-Dawley rats.

Authors:  Iwona Malicka; Katarzyna Siewierska; Bartosz Pula; Christopher Kobierzycki; Dominik Haus; Urszula Paslawska; Marek Cegielski; Piotr Dziegiel; Marzena Podhorska-Okolow; Marek Wozniewski
Journal:  Exp Biol Med (Maywood)       Date:  2015-05-19

6.  Protein kinase CK2: signaling and tumorigenesis in the mammary gland.

Authors:  E Landesman-Bollag; D H Song; R Romieu-Mourez; D J Sussman; R D Cardiff; G E Sonenshein; D C Seldin
Journal:  Mol Cell Biochem       Date:  2001-11       Impact factor: 3.396

Review 7.  Of mice and Myc: c-Myc and mammary tumorigenesis.

Authors:  M Hunter Jamerson; Michael D Johnson; Robert B Dickson
Journal:  J Mammary Gland Biol Neoplasia       Date:  2004-01       Impact factor: 2.673

Review 8.  Genetically engineered mouse models of mammary intraepithelial neoplasia.

Authors:  R D Cardiff; D Moghanaki; R A Jensen
Journal:  J Mammary Gland Biol Neoplasia       Date:  2000-10       Impact factor: 2.673

9.  Mechanism of inhibition of MMTV-neu and MMTV-wnt1 induced mammary oncogenesis by RARalpha agonist AM580.

Authors:  Y Lu; S Bertran; T-A Samuels; R Mira-y-Lopez; E F Farias
Journal:  Oncogene       Date:  2010-05-10       Impact factor: 9.867

10.  Distinct gene-expression profiles characterize mammary tumors developed in transgenic mice expressing constitutively active and C-terminally truncated variants of STAT5.

Authors:  Tali Eilon; Itamar Barash
Journal:  BMC Genomics       Date:  2009-05-18       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.